Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease, with
global public health impact affecting more than 25% of the global population. NAFLD is …

Objective The development of these updated clinical practice guidelines (CPG) was
commissioned by the American Association of Clinical Endocrinologists, The Obesity …

The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

Background & Aims Pharmacological management of obesity improves outcomes and
decreases the risk of obesity-related complications. This American Gastroenterological …

Background The prevalence of non-alcoholic fatty liver disease (NAFLD) has been
increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a …

Background & Aims Bariatric surgery is the most successful treatment for obesity. However,
many patients avoid surgery due to its perceived invasive nature and fear of complications …

Objective Little is known about the predictors of response to obesity interventions. Methods
In 450 participants with obesity, body composition, resting energy expenditure, satiety …

The complications associated with adult obesity are overwhelming national healthcare
systems. No country has yet implemented a successful population-level strategy to reverse …

The history of anti-obesity pharmacotherapies is marked by disappointments, often
entangled with societal pressure promoting weight loss and the prevailing conviction that …